MPS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from MPS Pharma Ltd. on BSE

Load latest

MPS Pharma Ltd.

23 Aug 2023

3.02

4.86%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Calling The Meeting Of Board Of …

BSE India

ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 ,inter alia, to consider and approve the notice calling the Annual General Meeting (AGM), Director's Report, Management Discussion and Analysis Report & Corporate Governance Report and Annexures thereto for the Financial Year 2022-23

pdf

MPS Pharma Ltd.

14 Aug 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

please find attached copy of newspaper publication

pdf

MPS Pharma Ltd.

12 Aug 2023

3.02

4.86%

Result

ADVIK LABORATORIES LTD. - 531686 - Submission Of Un-Audited Financial Results For The Quarter Ended 30Th …

BSE India

Please find attached unaudited fincial results for the quarter ended on 30th june, 2023

pdf

MPS Pharma Ltd.

12 Aug 2023

3.02

4.86%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Outcome for Outcome Of The Board Meeting And …

BSE India

This is to inform you that pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directorsof the Company in its meeting held on Saturday, 12th August, 2023 at 04:30 P.M atthe corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded just now and has, inter-alia, transacted the following business: 1. Considered and Approved the Standalone Un-audited Financial Results of the Company for the quarter ended 30th June, 2023. 2. Considered and Approved the Limited Review Report for the Un-audited Financial Results of the Company for the quarter ended 30th June, 2023. Further pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, a copy of the aforesaid Un-audited Financial Results for the quarter ended 30th June, 2023 along with Limited Review Report thereon is enclosed herewith for your kind perusal.

pdf

MPS Pharma Ltd.

02 Aug 2023

3.02

4.86%

Board Meeting

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Notice Of Board Meeting To Consider …

BSE India

ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Saturday, 12th August, 2023 at 04:30 P.M at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi- 110001 to inter-alia, consider and approve the Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter ended 30th June, 2023 and to carry on any other business with the permission of the Board.

pdf

MPS Pharma Ltd.

13 Jul 2023

3.02

4.86%

Company Update

ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appoitment of Mr. Ajay sharma as an additional director in a category of independent Director w.e.f 13.07.2023

pdf

MPS Pharma Ltd.

13 Jul 2023

3.02

4.86%

Corp. Note

ADVIK LABORATORIES LTD. - 531686 - Board Meeting Outcome for Outcome Of The Board Meeting Under …

BSE India

Pursuant to Regulation 30 read with Part A of Schedule IIIof SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company in its meeting held on Thursday, 13th July, 2023 at 03:30 P.M at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 04:18 P.M has, inter-alia, transacted the following business: 1. Considered and appointed Mr. Ajay Sharma (DIN: 03344008) as an Additional Director in the category of Independent Director of the Company. His appointment is subject to the approval of the shareholders at the ensuing Annual General Meeting. 2. Considered and accepted the resignation of Mr. Manoj Kumar Jain (DIN: 01887411) as an Independent Director of the Company, with effect from 04th July, 2023.

pdf